Arcadia Biosciences, Inc.
202 Cousteau Place
Suite 200
Davis
California
95618
United States
Tel: 530-756-7077
Fax: 530-756-7027
Website: http://www.arcadiabio.com/
Email: info@arcadiabio.com
185 articles about Arcadia Biosciences, Inc.
-
Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2023 Financial Results and Business Highlights Conference Call
3/14/2024
Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the fourth quarter and full year of 2023 after market close on March 28, 2024.
-
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2023 Financial Results and Business Highlights Conference Call
7/27/2023
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2023 after market close on August 10, 2023.
-
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call
3/22/2023
Arcadia Biosciences, Inc. today announced that it will release its 2022 fourth-quarter and full-year financial and business results after market close on March 30, 2023.
-
Arcadia Biosciences (RKDA) Announces CFO Transition
11/30/2022
Arcadia Biosciences, Inc.®, a producer and marketer of innovative, plant-based health and wellness products, announced that CFO Pam Haley will be leaving the company and will be replaced by Thomas J. Schaefer, effective January 3, 2023.
-
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights
11/10/2022
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2022.
-
Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call
10/27/2022
Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022.
-
Arcadia Biosciences (RKDA) to Participate in Upcoming Investor Conferences
8/31/2022
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that Stan Jacot, president and CEO and Pam Haley, CFO, will be participating in two investor conferences during the month of September.
-
Arcadia Biosciences (RKDA) Announces $5.0 Million Registered Direct Offering Priced At-The-Market
8/13/2022
Arcadia Biosciences, Inc.® announced that it has entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase and sale of 4,722,506 shares of its common stock at a purchase price of $1.05876 per share in a registered direct offering priced at-the-market under Nasdaq rules.
-
Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call
7/28/2022
Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022.
-
Arcadia Biosciences Announces Date of First Quarter 2022 Financial Results and Business Highlights Conference Call
5/5/2022
Arcadia Biosciences, Inc. today announced that it will release its financial and business results for the first quarter of 2022 after market close on May 12, 2022.
-
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights
3/30/2022
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2021.
-
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Conference Call
3/23/2022
Arcadia Biosciences, Inc. today announced that it will release its 2021 fourth-quarter and full-year financial and business results after market close on March 30, 2022 .
-
Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO
12/20/2021
Arcadia Biosciences, Inc. announced it has appointed Kevin Comcowich, current Chairman of the Arcadia Board of Directors, as interim chief executive officer, effective January 1, 2022.
-
Arcadia Biosciences (RKDA) Appoints Seasoned CPG Sales Executive Brian Schaffer to Senior Vice President of Sales
11/22/2021
Arcadia Biosciences, Inc. announced it has named Brian Schaffer as senior vice president of sales, as the company continues to expand its consumer goods platforms.
-
Arcadia Biosciences (RKDA) Announces Date of Third-Quarter 2021 Financial Results and Business Highlights Conference Call
11/8/2021
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), today announced that it will release its financial and business results for the third quarter and first nine months of 2021 after market close on November 15, 2021.
-
Arcadia Biosciences (RKDA) Announces Date of Second-Quarter and First-Half 2021 Financial Results and Business Highlights Conference Call
8/9/2021
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half 2021 after market close on August 16, 2021.
-
Arcadia Biosciences (RKDA) Names Veteran CPG Leader Laura Pitlik Chief Marketing Officer
7/20/2021
Arcadia Biosciences, Inc. announced it has named Laura Pitlik its chief marketing officer, as the company expands its consumer goods platforms following several key acquisitions.
-
Arcadia Biosciences Announces Date of First Quarter 2021 Financial Results and Business Highlights Conference Call
5/10/2021
Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops and food ingredients, today announced that it will release its financial and business results for the first quarter of 2021 after market close on May 17, 2021 .
-
Belinda Yao joins Arcadia Biosciences (RKDA) as Vice President of Operations
5/10/2021
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops and food ingredients, today announced that Belinda Yao has joined the company as vice president of operations
-
Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2020 Financial Results and Business Highlights Conference Call
3/23/2021
Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today announced that it will release its 2020 fourth-quarter and full-year financial and business results after market close on March 30, 2021 .